☆ 4.7 Article

Index60 Is Superior to HbA1c for Identifying Individuals at High Risk for Type 1 Diabetes

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Related references

Note: Only part of the references are listed.

Article Endocrinology & Metabolism

Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes

Brandon M. Nathan et al.

Summary: This study evaluated a new index, Index60, which can improve the metabolic staging of type 1 diabetes and accurately predict the risk of progression. By analyzing the participants' glucose and C-peptide levels, it was found that Index60 can identify individuals with characteristics of type 1 diabetes and their risk of progression is significantly higher than those staged only based on glucose levels.

DIABETES CARE (2022)

Add to Collection

Article Endocrinology & Metabolism

Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes

Brandon M. Nathan et al.

Summary: The study assessed the role of Index60 in the metabolic staging of type 1 diabetes, indicating that Index60 can identify individuals at risk for progression who may be missed by 2-hour glucose staging.

DIABETES CARE (2022)

Add to Collection

Article Endocrinology & Metabolism

Index60 as an additional diagnostic criterion for type 1 diabetes

Maria J. Redondo et al.

Summary: The study compared characteristics of individuals identified in the peri-diagnostic range by different glucose and C-peptide tests. Participants with high 2-hour glucose levels had older age, higher C-peptide responses, higher percentage of overweight/obesity, and lower multiple autoantibody positivity compared to those with high Index60 levels or both. Progression to diabetes was observed in participants with high glucose levels and/or high Index60 levels.

DIABETOLOGIA (2021)

Add to Collection

Article Endocrinology & Metabolism

The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening

Laura M. Jacobsen et al.

DIABETOLOGIA (2020)

Add to Collection

Article Endocrinology & Metabolism

Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children

Laura M. Jacobsen et al.

PEDIATRIC DIABETES (2019)

Add to Collection

Article Medicine, Research & Experimental

β Cell dysfunction exists more than 5 years before type 1 diabetes diagnosis

Carmella Evans-Molina et al.

JCI INSIGHT (2018)

Add to Collection

Article Endocrinology & Metabolism

Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018

DIABETES CARE (2018)

Add to Collection

Article Endocrinology & Metabolism

Dysglycemia and Index60 as Prediagnostic End Points for Type 1 Diabetes Prevention Trials

Brandon M. Nathan et al.

DIABETES CARE (2017)

Add to Collection

Review Endocrinology & Metabolism

Dysregulation of glucose metabolism in preclinical type 1 diabetes

Riitta Veijola et al.

PEDIATRIC DIABETES (2016)

Add to Collection

Article Endocrinology & Metabolism

Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association

Richard A. Insel et al.

DIABETES CARE (2015)

Add to Collection

Article Endocrinology & Metabolism

A New Approach for Diagnosing Type 1 Diabetes in Autoantibody-Positive Individuals Based on Prediction and Natural History

Jay M. Sosenko et al.

DIABETES CARE (2015)

Add to Collection

Article Endocrinology & Metabolism

Zinc Transporter-8 Autoantibodies Improve Prediction of Type 1 Diabetes in Relatives Positive for the Standard Biochemical Autoantibodies

Liping Yu et al.

DIABETES CARE (2012)

Add to Collection

Article Endocrinology & Metabolism

Performance of HbA1c as an Early Diagnostic Indicator of Type 1 Diabetes in Children and Youth

Kendra Vehik et al.

DIABETES CARE (2012)

Add to Collection

Article Endocrinology & Metabolism

Trends of Earlier and Later Responses of C-peptide to Oral Glucose Challenges With Progression to Type 1 Diabetes in Diabetes Prevention Trial-Type 1 Participants

Jay M. Sosenko et al.

DIABETES CARE (2010)

Add to Collection

Article Endocrinology & Metabolism

Harmonization of Glutamic Acid Decarboxylase and Islet Antigen-2 Autoantibody Assays for National Institute of Diabetes and Digestive and Kidney Diseases Consortia

Ezio Bonifacio et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)

Add to Collection

Article Endocrinology & Metabolism

The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results

Jeffrey L. Mahon et al.

PEDIATRIC DIABETES (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.